The evolving global landscape of first-in-class oncology drug innovation.
Saved in:
| Title: | The evolving global landscape of first-in-class oncology drug innovation. |
|---|---|
| Authors: | Mao X; Vanke School of Public Health, Tsinghua University, Beijing, China.; Institute for Healthy China, Tsinghua University, Beijing, China., Wang Z; Vanke School of Public Health, Tsinghua University, Beijing, China.; Institute for Healthy China, Tsinghua University, Beijing, China., Kong S; School of Basic Medical Sciences, Tsinghua University, Beijing, China., Yang Y; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China., Dreyer NA; University of North Carolina, Chapel Hill, NC, USA., Ba Y; Department of Oncology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China., Lotze MT; Departments of Surgery, Immunology and Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA., Zhan Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China. zhanqimin@bjmu.edu.cn.; Peking University International Cancer Institute, Beijing, China. zhanqimin@bjmu.edu.cn., Li G; Vanke School of Public Health, Tsinghua University, Beijing, China. guanqiaoli@tsinghua.edu.cn.; Institute for Healthy China, Tsinghua University, Beijing, China. guanqiaoli@tsinghua.edu.cn. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 May 11; Vol. 11 (1). Date of Electronic Publication: 2026 May 11. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42115599 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The evolving global landscape of first-in-class oncology drug innovation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mao+X%22">Mao X</searchLink>; Vanke School of Public Health, Tsinghua University, Beijing, China.; Institute for Healthy China, Tsinghua University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Vanke School of Public Health, Tsinghua University, Beijing, China.; Institute for Healthy China, Tsinghua University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Kong+S%22">Kong S</searchLink>; School of Basic Medical Sciences, Tsinghua University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.; Key Laboratory of Innovative Drug Research and Evaluation, National Medical Products Administration, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Dreyer+NA%22">Dreyer NA</searchLink>; University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ba+Y%22">Ba Y</searchLink>; Department of Oncology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Lotze+MT%22">Lotze MT</searchLink>; Departments of Surgery, Immunology and Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhan+Q%22">Zhan Q</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China. zhanqimin@bjmu.edu.cn.; Peking University International Cancer Institute, Beijing, China. zhanqimin@bjmu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Li+G%22">Li G</searchLink>; Vanke School of Public Health, Tsinghua University, Beijing, China. guanqiaoli@tsinghua.edu.cn.; Institute for Healthy China, Tsinghua University, Beijing, China. guanqiaoli@tsinghua.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2026 May 11; Vol. 11 (1). <i>Date of Electronic Publication: </i>2026 May 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42115599 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41392-026-02606-7 Languages: – Code: eng Text: English Titles: – TitleFull: The evolving global landscape of first-in-class oncology drug innovation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mao X – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Kong S – PersonEntity: Name: NameFull: Yang Y – PersonEntity: Name: NameFull: Dreyer NA – PersonEntity: Name: NameFull: Ba Y – PersonEntity: Name: NameFull: Lotze MT – PersonEntity: Name: NameFull: Zhan Q – PersonEntity: Name: NameFull: Li G IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 05 Text: 2026 May 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-3635 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Signal transduction and targeted therapy Type: main |
| ResultId | 1 |